1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків

The design and development of new phosphorus-containing amino acids and peptidomimetics have been attracting considerable attention due to their value as intermediates in the synthesis of biologically active compounds and the prospects for further pharmacological applications. 1,3-Oxazole derivative...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2022
Автори: Brusnakov, Mykhailo Y., Golovchenko, Oleksandr V., Potikha, Lyudmyla M., Brovarets, Volodymyr S.
Формат: Стаття
Мова:Англійська
Опубліковано: V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine 2022
Теми:
Онлайн доступ:https://bioorganica.com.ua/index.php/journal/article/view/14
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Ukrainica Bioorganica Acta
Завантажити файл: Pdf

Репозитарії

Ukrainica Bioorganica Acta
_version_ 1871193543278592000
author Brusnakov, Mykhailo Y.
Golovchenko, Oleksandr V.
Potikha, Lyudmyla M.
Brovarets, Volodymyr S.
author_facet Brusnakov, Mykhailo Y.
Golovchenko, Oleksandr V.
Potikha, Lyudmyla M.
Brovarets, Volodymyr S.
author_institution_txt_mv [ { "author": "Mykhailo Y. Brusnakov", "institution": "V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, 1 Murmanska St., Kyiv, 02094, Ukraine" }, { "author": "Oleksandr V. Golovchenko", "institution": "V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, 1 Murmanska St., Kyiv, 02094, Ukraine" }, { "author": "Lyudmyla M. Potikha", "institution": "V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, 1 Murmanska St., Kyiv, 02094, Ukraine" }, { "author": "Volodymyr S. Brovarets", "institution": "V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, 1 Murmanska St., Kyiv, 02094, Ukraine" } ]
author_sort Brusnakov, Mykhailo Y.
baseUrl_str https://bioorganica.com.ua/index.php/journal/oai
collection OJS
datestamp_date 2026-07-19T14:56:52Z
description The design and development of new phosphorus-containing amino acids and peptidomimetics have been attracting considerable attention due to their value as intermediates in the synthesis of biologically active compounds and the prospects for further pharmacological applications. 1,3-Oxazole derivatives, as masked peptides, constitute an important group of amino acid precursors that are widely used in contemporary organic synthesis. This review presents the 1,3-oxazole-based synthetic strategies of phosphorylated amino acids and peptides that have been published in both journal and patent literature. We have focused specifically on the synthesis of 4-phosphorylated 1,3-oxazoles as precursors of phosphopeptide mimetics containing the peptide chain with a non-terminal phosphono group due to the growing interest in finding efficient methods for the synthesis of this little-studied class of compounds.
doi_str_mv 10.15407/bioorganica2022.01.072
first_indexed 2025-07-17T12:19:24Z
format Article
fulltext ISSN 1814-9758. Ukr. Bioorg. Acta, 2022, Vol. 17, N 1 UDC 577.1:547.94 DOI: https://doi.org/10.15407/bioorganica2022.01.072 72 Ukrainica Bioorganica Acta www.bi oorgan ica .org .ua DIGEST PAPER 1,3-Oxazoles as precursors of phosphorylated amino acids and peptidomimetics Mykhailo Y. Brusnakov, Oleksandr V. Golovchenko, Lyudmyla M. Potikha, Volodymyr S. Brovarets* V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, 1 Murmanska St., Kyiv, 02094, Ukraine Abstract: The design and development of new phosphorus-containing amino acids and peptidomimetics have been attracting considerable attention due to their value as intermediates in the synthesis of biologically active compounds and the prospects for further pharmacological applications. 1,3-Oxazole derivatives, as masked peptides, constitute an important group of amino acid precursors that are widely used in contemporary organic synthesis. This review presents the 1,3-oxazole-based synthetic strategies of phosphorylated amino acids and peptides that have been published in both journal and patent literature. We have focused specifically on the synthesis of 4-phosphorylated 1,3-oxazoles as precursors of phosphopeptide mimetics containing the peptide chain with a non-terminal phosphono group due to the growing interest in finding efficient methods for the synthesis of this little-studied class of compounds. Keywords: phosphorylated amino acids; peptidomimetics; phosphorylated 1,3-oxazoles; synthesis. Introduction Structural analogues of peptides in which the aminocarboxylic acid group is replaced by the aminophosphonic acid group are well known today [1, 2]. A significant contribution to the development of chemistry of phosphonopeptidomimetics was made by V. P. Kukhar and a group of scientists from the Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine under his leadership. In particular, methods of synthesis were developed and the properties of a wide range of peptidomimetics, including those containing a phosphonate group, were studied. A significant amount of research has also been done in the field of chemistry of aminophosphonic acids and aminophosphonates as bioisosteric analogues of natural amino acids. The growing interest in this class of compounds is due to the fact Received: Revised: Accepted: Published online: 23.03.2022 08.04.2022 27.04.2022 30.06.2022  Corresponding author. Tel.: +380-44-573-2596; e-mail: brovarets@bpci.kiev.ua (V. S. Brovarets) ORCID: 0000-0001-6668-3412 that they have been found in biological systems [3] and are known to efficiently inhibit enzymes [4-6]. Phosphopeptide mimetic molecules can be structurally divided into two types: one containing the peptide chain with a terminal phosphono group (structures of type A, Figure 1) and the other with a nonterminal phosphorylated amino acid residue (structures of type B). The latter type has been much less studied, since phosphoamino acid group is difficult to introduce at certain internal positions of polypeptides. Peptidomimetics of this kind were applied to the synthesis of natural peptide compounds [7-13], thus adding to the biological significance of phosphopeptide mimetics. Reactions for obtaining type A peptides are described in the review of P. Kafarsky and B. Lejczak [14] as well as in the later publications [3, 15-17]. V. Brovarets, et al. [18] in 2019 made an attempt to systematize all-data on the synthetic methods and summarized properties of petidomimetics of type B. The general strategy of peptide synthesis of phosphorylated peptidomimetics, as well as classical peptides, involves the protection of functional groups with the subsequent formation of a peptide bond. The final stage of selective removal of protection is usually the most difficult. In this sense, synthetic schemes based on the use of P-substituted 1,3-oxazoles as masked amino acids have certain advantages due to the relative availability of such compounds and the ability to vary their structure in a fairly wide range. © Brusnakov M. Y. et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. mailto:brovarets@bpci.kiev.ua https://orcid.org/0000-0001-6167-076X Brusnakov M. Y. et al. 73 Figure 1. Structural types of phosphonopeptidomimetics. In this brief review, we present a selection of literature data published in the last years, concerning the synthesis of phosphorylated peptidomimetics of type B, as well as phosphorylated amino acids as precursors in the synthesis of such compounds, a method that includes, as a main step, oxazole ring cleavage. Synthesis on the base of aromatic 1,3-oxazoles The first example of the synthesis of phosphorylated amino acids using 1,3-oxazole derivatives was published by J. Rachon and U. Schollkopf [19] in 1981. Long-term storage of oxazoles 1 in methanol or ethanol with HCl yielded 2-(diethoxyphosphoryl)glycine esters 2 (Scheme 1). The use of HBr in AcOH gave 2-phosphonoglycine 3 after 48 hours. Reducing the reaction time to 3 min. yields a mixed esters 4. As expected, the oxazole is hydrolyzed first, followed by one of the two groups of the phosphonic acid ester. Scheme 1. Synthesis of phosphonoglycine derivatives from 5-alkoxy-1,3-oxazoles. Further, such a scheme was successfully implemented in the case of 5-amino-1,3-oxazole derivatives 5 [20] (Scheme 2). By solvolysis in 2 N ethanolic HCl were obtained the phosphonoglycine amide hydrochlorides 6. In contrast to the ring opening in EtOH, the cleavage in dilute aqueous HCl yielded amines 7, still formylated on amino group. The ring opening of an immonium salt 8 took place under very mild conditions: treatment with aqueous sodium hydrogen carbonate solution. The direct hydrolysis of the oxazoles 5 under the same weakly basic conditions was not observed. Scheme 2. Synthesis of phosphonoglycine derivatives from 5-amino-1,3-oxazoles. It should be noted that the most convenient and popular approach to a synthesis of 4-phosphorylated derivatives of 5-amino1,3-oxazoles is amination of 1-acyl(formyl)-2,2,2- trichloroethanephosphonates. The use of 2-substituted oxazoles allows obtaining the corresponding N-acyl derivatives of the target amino acids. Thus, 4-phosphorylated oxazoles 9 with isonipecotinic acid residues at position 5 were easily decomposed by the heating in an aqueous acetic acid to form the phosphorylated pseudopeptides 10 [21] (Scheme 3). Owing to the stability of the oxazol ring in an alkaline medium, the stepwise hydrolysis of the ester and diethoxyphosphoryl groups was carried out under the action of sodium hydroxide. Transformation of compounds 11 in to pseudopeptides 12 required longer treatment with acetic acid. In order to obtain phosphonopeptidomimetics that are containe acyclic amino alcohol group, oxazoles 13 cleavage with trifluoroacetic acid was used. In this case, depending on the temperature of the reaction, it is possible to obtain esters 14a or acids 14b [22, 23] (Scheme 4). Scheme 3. Synthesis of phosphorylated pseudopeptides with isonipecotinic acid residues 10, 12. The synthesis of peptidomimetics with terminal haloalkyl and thiocyanoalkyl substituents 15-17 was based on the interaction of compounds 13 with HCl, HI and HSCN, respectively, in anhydrous medium [24, 25]. Scheme 4. Synthesis and properties of phosphonopeptidomimetics containing acyclic amino alcohol groups. The hydrolytic decomposition of easily available phthalimido derivatives of 5-alkylamino-2-aminoalkyl-1,3- oxazol-4-ylphosphonic acids 18a-f in an acidic environment was performed on heating compounds 18 in 70% aqueous acetic acid, to form phthalimide-protected phospho- peptidemimetics 19 in high yields and without laborious purification [26] (Scheme 5). ISSN 1814-9758. Ukr. Bioorg. Acta, 2022, Vol. 17, N 1 74 Scheme 5. Synthesis phosphopeptidemimetics 19 from 5-alkylamino-2-aminoalkyl-1,3-oxazoles. The diethyl 5-amino-1,3-oxazol-4-ylphosphonates substituted at position 2 with aminoalkyl chain 20a, 23 have been used in the preparation of optically active phosphorylated peptidomimetics 22, 25 in which the introduced amino acid residues are not racemized [27]. Acylation of oxazole 20a with Z-(S)-Ala-OH under standard conditions of peptide synthesis, i.e. in a THF solution in the presence of 1-hydroxybenzotriazole (HOBt) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI), also leads only to amide (S)-21 (Scheme 6). Further oxazole ring opening in (S)-21 was carried out under mild conditions (in an AcOH-H2O mixture at 75 °C). Scheme 6. Preparation of optically active phosphorylated peptidomimetics 22, 25. A phosphorylated peptidomimetic of more complex structure 25 was obtained according to a similar scheme. Oxazole 23 was reacted with Z-protected optically active (S)-glutamine to give amide (S)-24 (Scheme 6) which yielded, on ring opening, peptidomimetic (S,R),(S,S)-25 containing the residues of four amino acids ((S)-glutamine, glycine, phosphorylated glycine, and isonipecotic acid) [27]. Scheme 7. Synthesis of phosphonodipeptides 28, 29, and 30. 5-Amino-1,3-oxazol-4-ylphosphonic acid derivatives 26, 27 containing a chiral aminoalkyl substituent on the 2-position of the oxazole ring have been used to obtain phosphonodipeptides 28, 29, and 30 with the original optical purity retained [28] (Scheme 7). Thus, oxazoles 26, when heated to 70 °С in 70% aqueous acetic acid, are cleaved to dipeptides 28 in 90-93% yields, with the phthaloyl protection of amino groups retained. Contrastingly, the action of acetic acid on oxazoles 27 leads to a mixture of unidentified products. To avoid later pathway the oxazole ring cleavage in these compounds was performed under milder conditions by using p-toluene- sulfonic acid in aqueous tetrahydrofuran at 20-25 °С. The resulting mimetics of phosphornopeptides 29 were isolated in 90-92% yields. A combined azlactone/oxazole strategy of the peptide synthesis was used to synthesize of phosphorylated peptidomimetics with dehydroamino acid residues [26]. On heating oxazoles 32 or 33, derived from 5-amino-2- aminoalkyl-1,3-oxazoles 20a,b, 31a-c, the oxazole ring opens in 70% aqueous acetic acid to give, in 79-94% yields, phosphorylated peptidomimetics 34 or 35 (Scheme 8). Scheme 8. A combined azlactone/oxazole strategy to peptidomimetics 34-36. To obtain reduced analogues of compounds 34, authors attempted, unsuccessfully, direct hydrogenation with zinc in an AcOH:HCl (10:3) mixture. In contrast, piperidyl derivatives of oxazoles 32 were thus reduced directly to peptidomimetics 36 in a good yield (53%-64%). The azlactone approach makes it possible to purposefully introduce dehydrtyrozine fragment into phosphorylated peptidomimetics. Thus, 1,3-oxazole derivatives 39 were obtained by reacting of 4-phosphorylated derivatives of 5-amino-2-aminoalkyl-1,3-oxazole 20a, 37 with 4-(4-aceto- xybenzylidene)-2-phenyl-1,3-oxazol-5-one 38 [29] (Scheme 9). Brusnakov M. Y. et al. 75 Scheme 9. Synthesis of phosphorylated tripeptides with a dehydrotyrosine fragment 40. Further compounds 39 were transformed into phosphorylated tripeptides 40 on heating in a mixture of acetic acid-water (5 : 1). In contrast to 4-phosphorylated derivatives of 5-amino- 1,3-oxazole, the corresponding 2,5-diamino derivatives are more sensitive to both acids and bases, which limits the availability of such compounds. Only two examples of 4-phosphorylated 2,5-diamino-1,3-oxazoles transformation to phosphonoglycine amide derivatives have been described in the literature [30]: treatment of oxazoles 41 with 2 N aqueous HCl led to the dipeptides 42 (Scheme 10). Scheme 10. Transformation of 4-phosphorylated 2,5-diamino-1,3- oxazoles. The possibility of splitting the 4-phosphorylated 5-mercapto-1,3-oxazoles under the action of acidic reagents were investigated and led to formation of phosphonoglycine thioderivatives [31]. In sequential hydrolysis of compounds 43 phosphonoglycine 44 was isolated (Scheme 11). Scheme 11. Hydrolysis of 5-mercapto-1,3-oxazole 43. Azlactone approach to the synthesis Azlactone derivatives are known for their hydrolytic sensitivity and propensity to open the oxazole cycle under fairly mild conditions, which is used in the synthesis of phosphorylated peptidomimetics. Thus, the phosphorus- containing peptidomimetics 46 were obtained in high yield under the action of phosphonoglycine amides 45 on 4-(4- methylbenzylidene)-4,5-dihydro-1,3-oxazol-5-one in benzene [32] (Scheme 12). Scheme 12. Synthesis of peptidomimetics 46 from phosphonoglycine amides. The high reactivity of azlactones in reactions with both nucleophilic and electrophilic reagents is used in a number of synthetic schemes for the construction of phosphorus- containing derivatives of oxazoles. The introduction of P-substituent can be carried out in several ways. The key step is based on Michael reaction. Scheme 13. Synthesis of -P-aspartic acid derivatives 47 and 48. For example, β-P-aspartic acid derivatives 47 and 48 were prepared by a one-pot method based on the interaction of 4-benzylidene-4,5-dihydro-5-oxazolone 49 and alkali dialkyl phosphites or ClSiMe3, followed by solvolysis with alcohols or water [33, 34] (Scheme 13). The products 47, 48 are isolated as a mixture of diastereomers with the ratio depending on the reaction conditions. The key step of solvolysis is the conversion of intermediate 5-siloxyoxazole derivatives 50 into hydrolytically unstable azlactons 51. In the reaction of 4-(phosphonomethyl) 5-siloxyoxazols 50a, 52 with NH-nucleophiles the corresponding amides 53 are formed (Scheme 14). Amines react with compounds 50 only after addition of alcohols. In order to study the stereochemical features of solvolysis of O-silylderivatives the method was extended to phenylphosphinates 54 that led to corresponding P-aspartic acid esters 55 [34] (Scheme 14). Scheme 14. Synthesis of -P-aspartic acid amides 53 and ethers 55. Silylphosphanes also gave 1,4-additions with the O=C-C=C moiety of azlactones to afford the adducts 56 [35]. Oxidation or sulfuration of 56 followed by hydrolysis led to oxophosphorus (or thiophosphorus) amido-acids 57 and 58 respectively (Scheme 15). ISSN 1814-9758. Ukr. Bioorg. Acta, 2022, Vol. 17, N 1 76 Scheme 15. Synthesis of oxyphosphorus (or thiophosphorus) amido-acids 57 and 58. A difference was observed in the behaviour of thiophosphane oxides 59a (R = Me) and 59b (R = Ph) toward hydrolysis: 59a led directly to the amido-acid 58 by opening of the lactonic ring whereas the heterocyclic intermediate 60 was isolated from 59b. Quaternary amino acids containing a geminal bisphosphonate moiety 61 have been synthesized by a two- step reaction sequence utilizes the Michael addition of α-substituted azlactones 62 to a vinylidene bisphosphonate 63 as the key step [36] (Scheme 16). Scheme 16. Synthesis of amino acid 61 with geminal bisphosphonate moiety. The reaction proceeds under catalytic conditions with excellent regioselectivity. Subsequently, acid-mediated azlactone ring opening affords the target quaternary amino acids with good overall yield. Reaction of azlactones 64 with triphenylvinylphospho- nium bromide afforded, through a Michael addition, the azlactones 65 [37] (Scheme 17). Intermediates 65 are transformed in good yields, without isolation, into the corresponding -aminoesters 66 or acids 67 functionalized with a triphenylphosphonium group by reaction with methanol, ethanol and p-TSA as catalyst or aqueous hydrogen bromide, respectively. Scheme 17. Reaction of azlactones with triphenylvinylphospho- nium bromide. The phosphonium salts 69 were obtained by N-acylglycine transformation to 4-phosphoranylidene- 5(4H)-oxazolones 68 and their subsequent alkylation (Scheme 18). Scheme 18. Synthesis of N-acyl-α-triphenylphosphonio-α-amino acid derivatives. C-Alkylation of 68 with a small alkyl group at position 4 express similar reactivity toward methanol [38, 39] or water [40, 41] as the protonated ylides. As a result the ring- opening reaction of oxazolone 70 proceeds, thus leading to the formation of corresponding N-acyl-α-triphenylphospho- nio-α-amino acid esters 70a or acid 70b. Acid hydrolysis of azlactone 68 directly, bypassing the alkylation step, leads to the amino acid derivatives 71a,b [40, 41]. Phosphorylated sarcosine derivatives 72a and 73 were obtained by the 1,3-oxazolone ring opening of saturated azlactones 74 and 75 with benzylamine. When hydrochloric acid is used, the complete hydrolysis of compound 74 to acid 72b occurs [42] (Scheme 19). Scheme 19. Synthesis of phosphorylated sarcosine derivatives. During efforts to find new approaches to the synthesis of natural amino acid L-phosphinothricin the hydrolysis of 4-[2-(P)ethyl]-1,3-oxazolidin-5-one derivatives 76a-c as useful initial building blocks was investigated [43, 44] (Scheme 20). Scheme 20. Synthesis of L-phosphinothricin derivatives. Brusnakov M. Y. et al. 77 The t-butyl per-2-ethylhexanoate-catalyzed reaction of diisopropylphosphite, dimethylphosphine oxide and isopropyl methylphosphinate with protected L-vinylglycine 77 afforded the oxazolidinones 76 in moderate yield. The hydrochlorides 78a,b were obtained as very hygroscopic crude products by acidic hydrolysis of 76a,b. Treatment of oxazolidinone 76c with an equimolar amount of NaOH in THF yielded N-acyl derivative 79, which could be hydrogenated to 80. Scheme 21. Synthesis of L-phosphinothricin 82. A technique involving simple acidic hydrolysis under heating with decarboxylation of the L-phosphinothricin-N- carboxylic anhydride 81 was patented for the synthesis of the optically pure L-phosphinothricin 82 [45] (Scheme 21). Synthesis based on oxazolidine derivatives Peptides containing phosphoamino acid (phosphotyrosine, phosphoserine, phosphotreonine) are useful tools for understanding signaling. Therefore, there is considerable interest in (-difluoroalkyl)phosphonates as analogues of natural phosphates. To construct such molecules, among others, a multi-stage synthetic scheme was used, which includes the ring opening cleavage of phosphorylated oxazolidine derivatives and the oxidation of intermediate alcohol at the final stage of synthesis. The key starting reagents are readily available from serine Garner’s aldehyde 83 and ether 84 (Scheme 22). -P-functionalyzed 4-ethyloxazolidines 85 are obtained in several stages using as a phosphorylating agent diethyl (difluoromethyl)- phosphonate. Dowex 50- [46] or HCl-mediated [47] N,O- acetal cleavage, followed by four-electron Corey-Schmidt [46] or Ru-catalyzed [47] oxidation of amino alcohols 86 yields the desired Boc-protected analogues of L-phosphoserine 87a and L-phosphoallothreonine 87b. Scheme 22. Synthesis of L-phosphoserine and L-phosphoallo- threonine analogues. A Horner-Wadsworth-Emmons reaction was performed on the aldehyde 83 and the resulting phosphonates 88 were obtained [48-50] (Scheme 23). Scheme 23. Synthesis of protected derivatives of 2-amino-4- phosphobutanoic acids 90a-c. The deprotections of 88 were successively performed in the presence of dihydrogen and palladium on activated carbon followed by an acidic treatment in alkanol [48] or without it in the case of increasing time of hydrogenation [49]. This two-step procedure gave the alcohol 89a. Then, the oxidation to the corresponding carboxylic acid 90a was carried out with a catalytic quantity of TEMPO [48] or under RuCl3/NaIO4 conditions. The convenient simultaneous deprotection and oxidation of intermediates 91 with the Jones reagent in acetone led to the protected aminoacids (R)-90a,b, in one step [49]. A similar sequence of transformations was patented for the synthesis of compound 90c [50]. Catalytic hydrogenation of allene 92, which was obtained in several steps using diethylchlorophosphite, led to oxazolidine 93. The later was transformed into (2R)-2- amino-5-phosphonopentanoic acid (AP5) 94 in a similar sequence of transformations [51] (Scheme 24). Scheme 24. Synthesis of AP5 94. Treatment of phosphine sulfide 95 (obtained in several steps from ester 84 and phosphine) (Scheme 25) with aqueous acid also had the desired effect of cleaving the oxazolidine ring. The reaction is followed by N-deprotection. The best method for oxidation of alcohol 96 was a pyridinium dichromate oxidation in the presence of molecular sieves, giving the (S)-2-[(tert-butoxycarbo- nyl)amino]-3-[(diphenylphosphino)sulfide]-1-propanoic acid 97 in >99% ee [52]. ISSN 1814-9758. Ukr. Bioorg. Acta, 2022, Vol. 17, N 1 78 Scheme 25. Synthesis of 3-[(diphenylphosphino)sulfide]-1- propanoic acid 97. An oxazolidinone ring also can be considered as a synthon for the synthesis of 2-amino alcohols, since it can be easily cleaved under mild conditions at the two heteroatoms. Thus, the (α,α-difluoroalkyl)phosphonate analogue of L-phosphoserine was obtained by base- mediated oxazolidinone ring cleavage of 98, followed by the oxidation under the Corey-Schmidt conditions that yield the desired protected phosphoserine analog 99 [53] (Scheme 26). Scheme 26. Synthesis of L-phosphoserine analogue 99. In the synthesis of phosphonic acid analogue of kainoids, the same strategy is used to build a synthetic scheme, which was implemented at the final stage of multistage transformation [54]. Cleavage of the oxazolidinone ring of compound 100 was achieved with aqueous base with subsequent protection of the nitrogen atom with a tert- butoxycarbonyl group to yield compound 101 (Scheme 27). Scheme 27. Synthesis of phosphonic acid analogue of kainoids 102. Oxidation of the primary hydroxy group with RuCl3/NaIO4 followed, without purification, by esterification with diazomethane gave fully protected ester 102 in 19.7% yield. Conclusions The strategy of constructing synthetic schemes based on 1,3-oxazole derivatives justifies itself both in the case of synthesis of individual phosphoaminic acids and more complex peptidomimetics. However, today, the goal of most work is still to obtain simpler phosphorylated amino acids. Most of these derivatives were obtained using popular approaches which includes the hydrolytic ring cleavage of aromatic oxazoles or azlactones at the final step. The analysis of literature data presented in this review indicates the prospects for further development of methods for modifying the structure of phosphorylated 1,3-oxazoles as key masked amino acids. Therefore, we hope that this review will help draw attention to such promising building blocks for the synthesis of peptides. Notes The authors declare no conflict of interest. Author contributions. The manuscript was written through the contributions of all authors. All authors have given approval to the final version of the manuscript. References 1. Aminophosphonic and aminophosphinic acids, Kukhar, V.; Hudson, H., Eds.; Wiley: New York, USA, 1999. 2. Amino acids, peptides and proteins in organic chemistry, Hugles, A., Ed.; Wiley-VCH: Weinheim, Germany, 2009. 3. Kafarski, P.; Lejezak, B. Aminophosphonic acids of potential medical importance. Curr. Med. Chem. 2001, 1, 301-312. 4. Lejezak, B.; Kafarski, P. Biological activity of aminophosphonic acids and their short peptides. Top. Heterocyclic Chem. 2009, 20, 31- 64. 5. Kunze, T.; Heps, S. Phosphono analogs of glutathione: inhibition of glutathione transferases, metabolic stability, and uptake by cancer cells. Biochem. Pharm. 2000, 59, 973-981. 6. Kazmaier, V., In Amino acids, peptides and proteins in organic chemistry, Hunghes A., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp 3-34. 7. Berwe, M.; Winfried, J.; Krüger, J.; Cancho-Crande, Y.; Lampe, T.; Michels, M.; Paulsen, H.; Raddatz, S.; Weigand, S. Scalable synthesis of the desoxy-biphenomycin B core. Org. Proc. Res. Dev. 2011, 15, 1348-1357. 8. Horenstein, B.; Nakanishi, K. Synthesis of unprotected (+-)-tuni- chrome An-1, a tunicate blood pigment. J. Am. Chem. Soc. 1989, 111, 6242-6247. 9. Kim, D.; Li, Y.; Horenstein, B.; Nakanishi, K. Synthesis of tunichromes mm-l and mm-2, blood pigments of the iron. Assimilating tunicate, molgula manhattensis. Tetrahedron Lett. 1990, 31, 7119-7122. 10. Schmidt, U.; Wild, I. Total synthesis of hexaacetylcelenamide A. Angew. Chem. 1984, 96, 996-998. 11. Schmidt, U.; Wild, I. Totalsynthese von Hexaacetylcelenamid A. Liebigs Ann. Chem. 1985, 9, 1882-1894 (in German). 12. Saavedra, C.; Boto, A.; Hernandes, R. “Customizable” units in di- and tripeptides: selective conversion into substituted dehydroamino acids. Org. Lett., 2012, 14, 3788-3791. 13. Kunze, T. Phosphono analogues of glutathione as new inhibitors of glutathione S-transferases. Arch. Pharm. 1996, 329, 503-509. 14. Kafarski, P.; Lejezak, B. In Synthesis of phosphono- and phosphinopeptides, Kukhar, V. P.; Hudson, H. R., Eds.; Aminophosphonic and aminiphosphinic acids: chemistry and biological activity; Wiley: New York, USA, 2000; pp 173-204. 15. Kukhar, V. P.; Romanenko, V. D. In Chemimistry of aminophosphonic acids and phosphonopeptides, Hughes, A. B., Ed.; Amino acids, peptides and proteins in organic chemistry; Wiley- VCH: Weinheim, Germany, 2009; Vol. 2, pp 189-260. 16. Han, L.; Hiratake, J.; Tachi, N.; Suzuki, H.; Kumagai, H.; Sakata, K. γ-(Monophenyl)phosphono glutamate analogues as mechanism-based inhibitors of γ-glutamyl transpeptidase. Bioorg. Med. Chem. 2006, 14, 6043-6054. 17. Zutphen, S.; Margarit, V.; Mora, G.; Floch, P. Readily available amino acid building blocks for the synthesis of phosphole-containing peptides. Tetrahedron Lett. 2007, 48, 2857-2850. 18. Brovarets, V. S.; Abdurakhmanova, E. R.; Golovchenko, A. V. In Phosphorylated peptidomimetics: synthesis and properties. Vovk, A.I., Ed.; Strategy of synthesis and bioactivity of organic molecules; Interservice: Kyiv, Ukraine, 2019; pp 223-248. 19. Rachón, J.; Schöllkopf, U. Synthese von Methyl(Ethy1-)- amino(diethoxyphosphory1)acetat sowie 2-Phosphonoglycin und seinen Derivaten aus (Isocyanmethyl)phosphonsäure-diethylester. Liebigs Ann. Chem. 1981, 1693-1698 (in German). 20. Röchr, G.; Schnell, M.; Köckritz, A. α-Substituted phosphonates; 61. Synthesis of 2-phosphonoglycine amides by solvolysis of 5-amino-4- phosphonooxazoles. Synthesis, 1992, 1992, 1031-1034. Brusnakov M. Y. et al. 79 21. Kondratyuk, K. M; Lukashuk, E. I.; Golovchenko, A. V.; Rusanov, E. B.; Brovarets, V. S. Reaction of diethyl 1-acylamino-2,2- dichloroethenylphosphonates with amino acids esters. Rus. J. Gen. Chem., 2012, 82, 643-651. 22. Abdurachmanova, E. R.; Lukashuk, E. I.; Golovchenko, A. V.; Brovarets, V. S. Synthesis of novel phosphono peptidomimetics. Rus. J. Gen. Chem., 2016, 86, 1206-1208. 23. Abdurakhmanova, E. R. Synthesis and properties of new 4-phosphorylated 5-(hydroxialkyl) amino-1,3-oxazoles. Ph.D. Dissertation (Chemistry), Kyiv, 2017 (in Ukrainian). 24. Abdurachmanova, E. R.; Holovchenko, O. V.; Brovarets, V. S. Interaction of diethyl [2-aryl-5-(hydroxyalkylamino)-1,3- oxazol]phosphonates with hydrogen chloride, hydrogen iodide and hydrogen thiocyanate. 11th National Symposium on Organic Chemistry, Warsaw, Poland, 2018, P-58. 25. Abdurachmanova, E. R.; Holovchenko, O. V.; Brovarets, V. S. In Fundamental and applied research in modern chemistry; Sukhoveeva, V. V., Ed.; Mykola Gogol Nizhyn State University: Nizhyn, Ukraine, 2018; pp 4-8. 26. Lukashuk, O. I.; Kondratyuk, K. M.; Golovchenko, A. V.; Brovarets, V. S.; Kukhar, V. P. A novel synthetic approach to phosphorylated peptidomimetics. Heteroatom Chem., 2013, 24, 289-297. 27. Kondratyuk, K. M.; Lukashuk, O. I.; Golovchenko, A. V.; Komarov, I. V.; Brovarets, V. S.; Kukhar, V. P. Synthesis of 5-amino-2- aminoalkyl-1,3-oxazol-4-ylphosphonic acid derivatives and their use in the preparation of phosphorylated peptidomimetics. Tetrahedron, 2013, 69, 6251-6261. 28. Lukashuk, O. I.; Abdurakhmanova, E. R.; Kondratyuk, K. M.; Golovchenko, A. V.; Khokhlov, K. V.; Brovarets, V. S.; Kukhar, V. P. Introduction of chiral 2-(aminoalkyl) substituents into 5-amino- 1,3-oxazol-4-ylphosphonic acid derivatives and their use in phosphonodipeptide synthesis. RSC Advances, 2015, 5, 11198-11206. 29. Lukashuk, E. I.; Abdurakhmanova, E. R.; Kondratyuk, K. M.; Golovchenko, A. V.; Brovarets, V. S. Synthesis of phosphorylated dehydrotyrosine-containing tripeptides from 5-amino-2-aminoalkyl- 1,3-oxazole-4-phosphonic acids derivatives. Rus. J. Gen. Chem., 2015, 85, 71-74. 30. Köckritz, A.; Schnell, M. α-Substituted phosphonates 68. α-Aminophosphonates and phosphono-substituted heterocycles from diethyl (2,2,2-trichloro-1-isocyanato-ethyl)phosphonate. Phosphorus, Sulfur, and Silicon, 1993, 83, 125-134. 31. Kondratyuk, K. M.; Lukashuk, E. I.; Golovchenko, A. V.; Vasilenko, A. N.; Brovarets, V. S. Synthesis and some properties of 4-phos- phorylated derivatives of 5-mercapto-1,3-oxazoles. Rus. J. Gen. Chem., 2013, 83, 46-53. 32. Lukashuk, O. I., Golovchenko, A. V., Golovchenko, O. I., Brovarets, V. S. New approach to synthese of peptidomimetics containing phosphonoglycine fragment. The 6th international conference chemistry of nitrogen containing heterocycles CNCH-2012, Kharkiv, Ukraine, 2012, P-56. 33. Preuβler, C.; Schnepp, K.; Kellner, K. Synthesis and characterization of β-phosphorous analogues of aspartic acid derivatives: 2-amino-3- aryl-3-phosphoryl-propionic acid derivatives. Liebigs Ann. Chem., 1991, 1165-1170 (in German). 34. Kellner, K.; Preuβler, C.; Schnepp, K. Diastereoselective synthetic ways to P-aspartic acid derivatives. Phosphorus, Sulfur, and Silicon, 1993, 76, 131-134. 35. El Mkadmi, M; Lazraq, M.; Kerbal, A.; Escudie, J.; Couret, C.; Ranaivonjatovo, H. From silylphosphanes and oxazolones to new phosphorus amido-acids. Phosphorus, Sulfur, and Silicon, 1998, 134- 135, 151-169. 36. Dzigielewski, M.; Hejmanowska, J.; Albrecht, L. A convenient approach to a novel group of quaternary amino acids containing a geminal bisphosphonate moiety. Synthesis, 2014, 46, 3233-3238. 37. Clerici, F.; Gelmi, M. L.; Pocar, D.; Rondena, R. 5(4H)-oxazolones. Part VIII. An efficient synthesis of Δ-pyrroline-2-carboxylic acid derivatives through Michael and Wittig condensation. Tetrahedron, 1995, 51, 9985-9994. 38. Grymel, M.; Kuźnik, A.; Mazurkiewicz, R. N-acyl-α- triphenylphosphonio-α-amino acid esters as synthetic equivalents of α-amino acid α-cations. Phosphorus, Sulfur, and Silicon, 2015, 190, 429-439. 39. Mazurkiewicz, R.; Grymel, M. Reaction of N-acyl-α- triphenylphosphonio-α-amino acid esters with organic bases: mechanism of the base-catalyzed nucleophilic substitution of the triphenylphosphonium group. Monatsh. Chem., 2002, 133, 1197- 1204. 40. Mazurkiewicz, R.; Październiok-Holewa, A.; Grymel, M. N-Acyl-α- triphenylphosphonio-α-amino acids: synthesis and decarboxylation toα-(N-acylamino)alkyltriphenylphosphonium salts. Phosphorus, Sulfur, and Silicon, 2009, 184, 1017-1027. 41. Mazurkiewicz, R.; Październiok-Holewa, A.; Grymel, M. Synthesis and decarboxylation of N-acyl-α-triphenylphosphonio-α-amino acids: a new synthesis of α-(N-acylamino)alkyltriphenylphosphonium salts. Tetrahedron Lett., 2008, 49, 1801-1803. 42. Burger, K.; Heistracher, E.; Simmerl, R.; Eggersdorfer, M. Application of hexafluoroacetone as protecting and activating reagent in amino acid and peptide chemistry. Synthesis of phosphorus containing sarcosine derivatives via a new electrophilic sarcosine synthone. Z. Naturforsch., 1992, 47, 424-433 (in German). 43. Zeiss, H.-J. Enantioselective synthesis of L-phosphinothricin from L-methionine and L-glutamic acid via L-vinylglycine. Tetrahedron, 1992, 48, 8263-8270. 44. US Patent No 5374736 A. L-4-(phosphinylethyl)-1,3-oxazolidin-5- one derivatives as intermediates for synthesis of phosphorus- containing L-amino acids / Zeiss, H.-J. Patent appl. No 17405 12.02.1993. Publ. 20.12.1994. 45. CN Patent No 104558033 A. L-glufosinates-N-carboxylic acid anhydride, and preparation and application thereof / Wang, Y.; Zhu, B.; Wu, D. Patent appl. No 201410797907 19.12.2014. Publ. 29.04.2015 (in Chinese). 46. Berkowitz, D. B.; Eggen, M. J.; Shen, Q.; Shoemaker, R. K. Ready access to fluorinated phosphonate mimics of secondary phosphates. Synthesis of the (α,α-difluoroalkyl)phosphonate analogues of L-phosphoserine, L-phosphoallothreonine, and L-phosphothreonine. J. Org. Chem., 1996, 61, 4666-4675. 47. Otaka, A.; Miyoshi, K.; Burke Jr., T. R.; Roller, P. P.; Kubota, H.; Tamamura, H.; Fujii, N. Synthesis and application of N-Boc-L-2- amino-4-(diethylphosphono)-4,4-difluorobutanoic acid for solid- phase synthesis of nonhydrolyzablephosphoserine peptide analogues. Tetrahedron Lett., 1995, 36, 927-930. 48. Cortes-Clerget, M.; Gager, O.; Monteil, M.; Pirat, J.-L.; Migianu- Griffoni, E.; Deschamp, J.; Lecouvey, M. Novel easily recyclable bifunctional phosphonic acid carrying tripeptides for the stereoselective Michael addition of aldehydes with nitroalkenes. Adv. Synth. Catal., 2016, 358, 34-40. 49. Foss Jr., Frank W.; Snyder, A. H.; Davis, M. D.; Rouse, M.; Okusa, M. D.; Lynch, K. R.; Macdonald, T. L. Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg. Med. Chem., 2007, 15, 663-677. 50. WO Patent No 2017/165416 A1. Protected derivatives of 2-amino-4- phophobutanoic acid / Findeis, M. A. Patent appl. No PCT/US2017/023414 21.03.2017. Publ. 28.09.2017. 51. Muller, M.; Mann, A.; Taddei, M. A new method for the preparation of (2R)-2-amino-5-phosphonopentanoic acid. Tetrahedron Lett., 1993, 34, 3289-3290. 52. Porte, A. M.; van der Donk, W. A.; Burgess, K. New and efficient synthesis of an amino acid for preparing phosphine-functionalized peptidomimetics. J. Org. Chem., 1998, 63, 5262-5264. 53. Berkowitz, D. B.; Shen, Q.; Maeng, J.-H. Synthesis of the (α,α-difluoroalkyl)phosphonate analogue of phosphoserine. Tetrahedron Lett., 1994, 35, 6445-6448. 54. Yuasa, Y.; Fujimaki, N.; Yokomatsu, T.; Ando, J.; Shibuya, Sh. Diastereoselective synthesis of ω-posphonic acid anlogues of 4-arylkainoids. J. Chem. Soc. Perkin Trans. 1., 1998, 3577-3584. ISSN 1814-9758. Ukr. Bioorg. Acta, 2022, Vol. 17, N 1 80 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків М. Ю. Бруснаков, О. В. Головченко, Л. М. Потіха, В. С. Броварець* Інститут біоорганічної хімії та нафтохімії ім. В.П. Кухаря НАН України, вул. Мурманська, 1, Київ, 02094, Україна Резюме: Розробка нових фосфоровмісних амінокислот і пептидоміметиків привертає значну увагу через їх значення як проміжних продуктів у синтезі деяких біологічно активних речовин та перспективність подальшого фармакологічного застосування. Похідні 1,3-оксазолу, як замасковані пептиди, становлять важливу групу попередників амінокислот і широко використовуються у сучасному органічному синтезі. У цьому огляді представлено узагальнення синтетичних стратегій фосфорильованих амінокислот і пептидів на основі 1,3-оксазолу, опублікованих як у журнальній, так і в патентній літературі. Ми зосередили свою увагу на 4-фосфорильованих 1,3-оксазолах, як попередниках фосфопептидних міметиків з некінцевою фосфоногрупою в пептидному ланцюгу, у зв’язку із зростаючим інтересом до пошуку ефективних методів синтезу цього ще малодослідженого класу сполук. Ключові слова: фосфорильовані амінокислоти; пептидоміметики; фосфорильовані 1,3-оксазоли; синтез.
id oai:ojs2.bioorganica.com.ua:article-14
institution Ukrainica Bioorganica Acta
keywords_txt_mv keywords
language English
last_indexed 2026-07-20T01:00:23Z
publishDate 2022
publisher V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine
record_format ojs
resource_txt_mv bioorganicacomua/ab/23894fc3a012104281346bec04f9b2ab.pdf
spelling oai:ojs2.bioorganica.com.ua:article-142026-07-19T14:56:52Z 1,3-Oxazoles as precursors of phosphorylated amino acids and peptidomimetics 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків Brusnakov, Mykhailo Y. Golovchenko, Oleksandr V. Potikha, Lyudmyla M. Brovarets, Volodymyr S. phosphorylated amino acids peptidomimetics phosphorylated 1,3-oxazoles synthesis фосфорильовані амінокислоти пептидоміметики фосфорильовані 1,3-оксазоли синтез The design and development of new phosphorus-containing amino acids and peptidomimetics have been attracting considerable attention due to their value as intermediates in the synthesis of biologically active compounds and the prospects for further pharmacological applications. 1,3-Oxazole derivatives, as masked peptides, constitute an important group of amino acid precursors that are widely used in contemporary organic synthesis. This review presents the 1,3-oxazole-based synthetic strategies of phosphorylated amino acids and peptides that have been published in both journal and patent literature. We have focused specifically on the synthesis of 4-phosphorylated 1,3-oxazoles as precursors of phosphopeptide mimetics containing the peptide chain with a non-terminal phosphono group due to the growing interest in finding efficient methods for the synthesis of this little-studied class of compounds. Розробка нових фосфоровмісних амінокислот і пептидоміметиків привертає значну увагу через їх значення як проміжних продуктів у синтезі деяких біологічно активних речовин та перспективність подальшого фармакологічного застосування. Похідні 1,3-оксазолу, як замасковані пептиди, становлять важливу групу попередників амінокислот і широко використовуються у сучасному органічному синтезі. У цьому огляді представлено узагальнення синтетичних стратегій фосфорильованих амінокислот і пептидів на основі 1,3-оксазолу, опублікованих як у журнальній, так і в патентній літературі. Ми зосередили свою увагу на 4-фосфорильованих 1,3-оксазолах, як попередниках фосфопептидних міметиків з некінцевою фосфоногрупою в пептидному ланцюгу, у зв’язку із зростаючим інтересом до пошуку ефективних методів синтезу цього ще малодослідженого класу сполук. V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine 2022-06-30 Article Article application/pdf https://bioorganica.com.ua/index.php/journal/article/view/14 10.15407/bioorganica2022.01.072 Ukrainica Bioorganica Acta; Vol. 17 No. 1 (2022): Ukrainica Bioorganica Acta; 72-80 Ukrainica Bioorganica Acta; Том 17 № 1 (2022): Ukrainica Bioorganica Acta; 72-80 1814-9766 1814-9758 10.15407/bioorganica2022.01 en https://bioorganica.com.ua/index.php/journal/article/view/14/18 Copyright (c) 2022 Mykhailo Y. Brusnakov, Oleksandr V. Golovchenko, Lyudmyla M. Potikha, Volodymyr S. Brovarets https://creativecommons.org/licenses/by/4.0
spellingShingle фосфорильовані амінокислоти
пептидоміметики
фосфорильовані 1,3-оксазоли
синтез
Brusnakov, Mykhailo Y.
Golovchenko, Oleksandr V.
Potikha, Lyudmyla M.
Brovarets, Volodymyr S.
1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
title 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
title_alt 1,3-Oxazoles as precursors of phosphorylated amino acids and peptidomimetics
title_full 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
title_fullStr 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
title_full_unstemmed 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
title_short 1,3-Оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
title_sort 1,3-оксазоли як попередники фосфорильованих амінокислот і пептидоміметиків
topic фосфорильовані амінокислоти
пептидоміметики
фосфорильовані 1,3-оксазоли
синтез
topic_facet phosphorylated amino acids
peptidomimetics
phosphorylated 1,3-oxazoles
synthesis
фосфорильовані амінокислоти
пептидоміметики
фосфорильовані 1,3-оксазоли
синтез
url https://bioorganica.com.ua/index.php/journal/article/view/14
work_keys_str_mv AT brusnakovmykhailoy 13oxazolesasprecursorsofphosphorylatedaminoacidsandpeptidomimetics
AT golovchenkooleksandrv 13oxazolesasprecursorsofphosphorylatedaminoacidsandpeptidomimetics
AT potikhalyudmylam 13oxazolesasprecursorsofphosphorylatedaminoacidsandpeptidomimetics
AT brovaretsvolodymyrs 13oxazolesasprecursorsofphosphorylatedaminoacidsandpeptidomimetics
AT brusnakovmykhailoy 13oksazoliâkpoperednikifosforilʹovanihamínokislotípeptidomímetikív
AT golovchenkooleksandrv 13oksazoliâkpoperednikifosforilʹovanihamínokislotípeptidomímetikív
AT potikhalyudmylam 13oksazoliâkpoperednikifosforilʹovanihamínokislotípeptidomímetikív
AT brovaretsvolodymyrs 13oksazoliâkpoperednikifosforilʹovanihamínokislotípeptidomímetikív